PCYT2 and type 2 diabetes mellitus: In summary, we have demonstrated the reduction of PE in the liver in T2DM and its possible mechanism, which emphasizes the importance of PE produced by the PCYT2 pathway and opens new avenues for the treatment of liver injury in patients with T2DM in the future.